ZIVO Bioscience, Inc. (ZIVOW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 33.24M |
| Enterprise Value | 33.81M |
| P/E Ratio | -1.42 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 120.55 |
| Price/Book Ratio | -3.82 |
| Enterprise/Revenue | 125.34 |
| Enterprise/EBITDA | -1.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -83.11 |
| Operating Margin | -82.79 |
| Return On Assets | -14.91 |
| Return On Equity | 3.54 |
| Revenue | 119,025 |
| Revenue/Share | 0.03 |
| Gross Profit | 39,934 |
| EBITDA | -9.84M |
| Net Income | -9.89M |
| Diluted EPS | -2.59 |
| Total Cash | 67,058 |
| Total Cash/Share | 0.02 |
| Total Debt | 637,202 |
| Total Debt/Equity | -0.17 |
| Current Ratio | 0.1 |
| Book Value Per Share | -0.96 |
| 52-Week Change | -96.56 |
| 52-Week High | 0.04 |
| 52-Week Low | 0.04 |
| Moving Average 50 Days | 0.83 |
| Moving Average 200 Days | 0.83 |
| Average Volume | 4,389 |
| Shares Outstanding | 3.73M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |